Status:

COMPLETED

Effectiveness of Zinc Supplementation in Management of Patients With Symptomatic Benign Migratory Glossitis

Lead Sponsor:

mariam hamouda

Conditions:

Benign Migratory Glossitis

Eligibility:

All Genders

18-60 years

Phase:

PHASE4

Brief Summary

Effectiveness of Zinc Supplementation in management of patients with symptomatic Benign Migratory Glossitis. Zinc supplements seems to be a therapeutic option as Migratory glossitis is a chronic dise...

Detailed Description

Forty-eight patients diagnosed with symptomatic benign migratory glossitis will be selected from Oral Medicine, Periodontology and Oral Diagnosis department, Faculty of dentistry, Ain shams university...

Eligibility Criteria

Inclusion

  • Both genders are eligible.
  • Adults above 18 years old.
  • Patients who presented at the control checkup with constant atrophic areas with raised keratotic margins.
  • Patients who diagnosed with symptomatic geographic tongue.

Exclusion

  • Patients with anemia, oral candidiasis, and indicators for localized irritations (dental caries, affected teeth, sharp teeth edges, dental calculus, faulty dental fillings, and faulty prosthetic procedures).
  • Psoriatic patients.
  • Vulnerable patients (Prisoners, persons with mental disabilities or physical handicaps, children, neonates and pregnant women)

Key Trial Info

Start Date :

September 6 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 30 2023

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT05190562

Start Date

September 6 2021

End Date

May 30 2023

Last Update

August 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ain Shams University

Cairo, Egypt, 12345